nodes	percent_of_prediction	percent_of_DWPC	metapath
Diclofenac—CYP1A1—head and neck cancer	0.29	0.615	CbGaD
Diclofenac—PTGS2—head and neck cancer	0.181	0.385	CbGaD
Diclofenac—ABCC4—Fluorouracil—head and neck cancer	0.0733	0.252	CbGbCtD
Diclofenac—ABCC1—Vinblastine—head and neck cancer	0.0545	0.188	CbGbCtD
Diclofenac—ABCC1—Docetaxel—head and neck cancer	0.045	0.155	CbGbCtD
Diclofenac—ALB—Fluorouracil—head and neck cancer	0.0272	0.0936	CbGbCtD
Diclofenac—CYP2C8—Fluorouracil—head and neck cancer	0.021	0.0723	CbGbCtD
Diclofenac—CYP1A2—Fluorouracil—head and neck cancer	0.0162	0.056	CbGbCtD
Diclofenac—CYP2C9—Fluorouracil—head and neck cancer	0.0146	0.0504	CbGbCtD
Diclofenac—ABCB1—Vinblastine—head and neck cancer	0.0132	0.0454	CbGbCtD
Diclofenac—ABCB1—Docetaxel—head and neck cancer	0.0108	0.0374	CbGbCtD
Diclofenac—CYP3A4—Vinblastine—head and neck cancer	0.00789	0.0272	CbGbCtD
Diclofenac—CYP3A4—Docetaxel—head and neck cancer	0.0065	0.0224	CbGbCtD
Diclofenac—PLA2G2A—tongue—head and neck cancer	0.00174	0.0662	CbGeAlD
Diclofenac—ASIC1—saliva-secreting gland—head and neck cancer	0.00129	0.0492	CbGeAlD
Diclofenac—PLA2G2A—mouth—head and neck cancer	0.00117	0.0445	CbGeAlD
Diclofenac—CXCR1—lymph node—head and neck cancer	0.000825	0.0314	CbGeAlD
Diclofenac—Bromfenac—PTGS2—head and neck cancer	0.000812	0.212	CrCbGaD
Diclofenac—PLA2G2A—saliva-secreting gland—head and neck cancer	0.00078	0.0297	CbGeAlD
Diclofenac—PTGS2—cartilage tissue—head and neck cancer	0.000756	0.0288	CbGeAlD
Diclofenac—TTR—neck—head and neck cancer	0.000755	0.0287	CbGeAlD
Diclofenac—PLA2G2A—connective tissue—head and neck cancer	0.000717	0.0273	CbGeAlD
Diclofenac—Clonidine—CYP1A1—head and neck cancer	0.000711	0.186	CrCbGaD
Diclofenac—ASIC1—head—head and neck cancer	0.000701	0.0266	CbGeAlD
Diclofenac—Lumiracoxib—PTGS2—head and neck cancer	0.00069	0.18	CrCbGaD
Diclofenac—PLA2G2A—epithelium—head and neck cancer	0.00068	0.0259	CbGeAlD
Diclofenac—Nepafenac—PTGS2—head and neck cancer	0.000656	0.172	CrCbGaD
Diclofenac—PLA2G2A—trachea—head and neck cancer	0.000602	0.0229	CbGeAlD
Diclofenac—CXCL8—trachea—head and neck cancer	0.000596	0.0227	CbGeAlD
Diclofenac—ABCC1—hair follicle—head and neck cancer	0.000593	0.0225	CbGeAlD
Diclofenac—KCNQ3—head—head and neck cancer	0.000557	0.0212	CbGeAlD
Diclofenac—TTR—connective tissue—head and neck cancer	0.000541	0.0206	CbGeAlD
Diclofenac—Meclofenamic acid—PTGS2—head and neck cancer	0.000538	0.141	CrCbGaD
Diclofenac—PLA2G2A—lymphoid tissue—head and neck cancer	0.000524	0.0199	CbGeAlD
Diclofenac—KCNQ2—head—head and neck cancer	0.000513	0.0195	CbGeAlD
Diclofenac—ASIC1—lymph node—head and neck cancer	0.000491	0.0187	CbGeAlD
Diclofenac—ALOX5—connective tissue—head and neck cancer	0.00049	0.0187	CbGeAlD
Diclofenac—PLA2G2A—thyroid gland—head and neck cancer	0.000476	0.0181	CbGeAlD
Diclofenac—PLA2G2A—head—head and neck cancer	0.000422	0.0161	CbGeAlD
Diclofenac—Mefenamic acid—PTGS2—head and neck cancer	0.000418	0.109	CrCbGaD
Diclofenac—SLCO1C1—thyroid gland—head and neck cancer	0.000402	0.0153	CbGeAlD
Diclofenac—TTR—lymphoid tissue—head and neck cancer	0.000396	0.015	CbGeAlD
Diclofenac—SCN4A—thyroid gland—head and neck cancer	0.000369	0.0141	CbGeAlD
Diclofenac—CYP1A1—mouth—head and neck cancer	0.000366	0.0139	CbGeAlD
Diclofenac—TTR—thyroid gland—head and neck cancer	0.000359	0.0137	CbGeAlD
Diclofenac—ALOX5—lymphoid tissue—head and neck cancer	0.000358	0.0136	CbGeAlD
Diclofenac—SLCO1C1—head—head and neck cancer	0.000357	0.0136	CbGeAlD
Diclofenac—Haemoglobin—Hydroxyurea—head and neck cancer	0.000344	0.00281	CcSEcCtD
Diclofenac—Haemorrhage—Hydroxyurea—head and neck cancer	0.000342	0.0028	CcSEcCtD
Diclofenac—Hallucination—Hydroxyurea—head and neck cancer	0.000341	0.00278	CcSEcCtD
Diclofenac—Colitis—Docetaxel—head and neck cancer	0.00034	0.00278	CcSEcCtD
Diclofenac—Irritability—Fluorouracil—head and neck cancer	0.00034	0.00278	CcSEcCtD
Diclofenac—Skin exfoliation—Docetaxel—head and neck cancer	0.000338	0.00276	CcSEcCtD
Diclofenac—Fluid retention—Docetaxel—head and neck cancer	0.000336	0.00275	CcSEcCtD
Diclofenac—Alopecia—Vinblastine—head and neck cancer	0.000332	0.00271	CcSEcCtD
Diclofenac—SCN4A—head—head and neck cancer	0.000328	0.0125	CbGeAlD
Diclofenac—Dry skin—Fluorouracil—head and neck cancer	0.000327	0.00267	CcSEcCtD
Diclofenac—ALOX5—thyroid gland—head and neck cancer	0.000326	0.0124	CbGeAlD
Diclofenac—ABCC1—parotid gland—head and neck cancer	0.000324	0.0123	CbGeAlD
Diclofenac—Oesophagitis—Docetaxel—head and neck cancer	0.000324	0.00264	CcSEcCtD
Diclofenac—TTR—head—head and neck cancer	0.000319	0.0121	CbGeAlD
Diclofenac—Nasopharyngitis—Fluorouracil—head and neck cancer	0.000319	0.0026	CcSEcCtD
Diclofenac—Lightheadedness—Docetaxel—head and neck cancer	0.000317	0.00259	CcSEcCtD
Diclofenac—Muscular weakness—Fluorouracil—head and neck cancer	0.000314	0.00257	CcSEcCtD
Diclofenac—Angiopathy—Hydroxyurea—head and neck cancer	0.000311	0.00254	CcSEcCtD
Diclofenac—Sepsis—Docetaxel—head and neck cancer	0.000307	0.00251	CcSEcCtD
Diclofenac—Chills—Hydroxyurea—head and neck cancer	0.000307	0.00251	CcSEcCtD
Diclofenac—PTGS2—mouth—head and neck cancer	0.000307	0.0117	CbGeAlD
Diclofenac—Eosinophilia—Fluorouracil—head and neck cancer	0.000305	0.00249	CcSEcCtD
Diclofenac—Ill-defined disorder—Vinblastine—head and neck cancer	0.000303	0.00248	CcSEcCtD
Diclofenac—Alopecia—Hydroxyurea—head and neck cancer	0.000303	0.00247	CcSEcCtD
Diclofenac—Anaemia—Vinblastine—head and neck cancer	0.000302	0.00247	CcSEcCtD
Diclofenac—Angina pectoris—Fluorouracil—head and neck cancer	0.0003	0.00245	CcSEcCtD
Diclofenac—Phlebitis—Docetaxel—head and neck cancer	0.000299	0.00244	CcSEcCtD
Diclofenac—Erythema—Hydroxyurea—head and neck cancer	0.000298	0.00243	CcSEcCtD
Diclofenac—PLA2G2A—lymph node—head and neck cancer	0.000296	0.0112	CbGeAlD
Diclofenac—Malaise—Vinblastine—head and neck cancer	0.000295	0.00241	CcSEcCtD
Diclofenac—Vertigo—Vinblastine—head and neck cancer	0.000294	0.0024	CcSEcCtD
Diclofenac—CXCL8—lymph node—head and neck cancer	0.000293	0.0111	CbGeAlD
Diclofenac—Leukopenia—Vinblastine—head and neck cancer	0.000293	0.00239	CcSEcCtD
Diclofenac—Pancytopenia—Fluorouracil—head and neck cancer	0.000292	0.00239	CcSEcCtD
Diclofenac—Swelling—Docetaxel—head and neck cancer	0.000292	0.00238	CcSEcCtD
Diclofenac—ALOX5—head—head and neck cancer	0.000289	0.011	CbGeAlD
Diclofenac—Deafness—Docetaxel—head and neck cancer	0.000287	0.00235	CcSEcCtD
Diclofenac—Upper respiratory tract infection—Fluorouracil—head and neck cancer	0.000286	0.00234	CcSEcCtD
Diclofenac—Hepatic failure—Docetaxel—head and neck cancer	0.000286	0.00234	CcSEcCtD
Diclofenac—Cardiac failure congestive—Docetaxel—head and neck cancer	0.000284	0.00232	CcSEcCtD
Diclofenac—Convulsion—Vinblastine—head and neck cancer	0.000283	0.00231	CcSEcCtD
Diclofenac—Hypertension—Vinblastine—head and neck cancer	0.000282	0.0023	CcSEcCtD
Diclofenac—Photosensitivity reaction—Fluorouracil—head and neck cancer	0.000281	0.0023	CcSEcCtD
Diclofenac—Ill-defined disorder—Hydroxyurea—head and neck cancer	0.000277	0.00226	CcSEcCtD
Diclofenac—Pneumonia—Fluorouracil—head and neck cancer	0.000276	0.00226	CcSEcCtD
Diclofenac—Anaemia—Hydroxyurea—head and neck cancer	0.000276	0.00225	CcSEcCtD
Diclofenac—Discomfort—Vinblastine—head and neck cancer	0.000275	0.00225	CcSEcCtD
Diclofenac—Infestation—Fluorouracil—head and neck cancer	0.000275	0.00224	CcSEcCtD
Diclofenac—Infestation NOS—Fluorouracil—head and neck cancer	0.000275	0.00224	CcSEcCtD
Diclofenac—Visual disturbance—Docetaxel—head and neck cancer	0.000271	0.00222	CcSEcCtD
Diclofenac—Acute coronary syndrome—Fluorouracil—head and neck cancer	0.000271	0.00221	CcSEcCtD
Diclofenac—Renal impairment—Docetaxel—head and neck cancer	0.00027	0.00221	CcSEcCtD
Diclofenac—Neuropathy peripheral—Fluorouracil—head and neck cancer	0.000269	0.0022	CcSEcCtD
Diclofenac—Myocardial infarction—Fluorouracil—head and neck cancer	0.000269	0.0022	CcSEcCtD
Diclofenac—Dermatitis bullous—Docetaxel—head and neck cancer	0.000269	0.0022	CcSEcCtD
Diclofenac—Malaise—Hydroxyurea—head and neck cancer	0.000269	0.0022	CcSEcCtD
Diclofenac—Stomatitis—Fluorouracil—head and neck cancer	0.000268	0.00219	CcSEcCtD
Diclofenac—Conjunctivitis—Fluorouracil—head and neck cancer	0.000267	0.00218	CcSEcCtD
Diclofenac—Urinary tract infection—Fluorouracil—head and neck cancer	0.000267	0.00218	CcSEcCtD
Diclofenac—Leukopenia—Hydroxyurea—head and neck cancer	0.000267	0.00218	CcSEcCtD
Diclofenac—Cardiac failure—Docetaxel—head and neck cancer	0.000264	0.00215	CcSEcCtD
Diclofenac—Lethargy—Docetaxel—head and neck cancer	0.000262	0.00214	CcSEcCtD
Diclofenac—Thrombocytopenia—Vinblastine—head and neck cancer	0.000261	0.00213	CcSEcCtD
Diclofenac—Epistaxis—Fluorouracil—head and neck cancer	0.000259	0.00211	CcSEcCtD
Diclofenac—Convulsion—Hydroxyurea—head and neck cancer	0.000258	0.00211	CcSEcCtD
Diclofenac—Sinusitis—Fluorouracil—head and neck cancer	0.000258	0.0021	CcSEcCtD
Diclofenac—Pain in extremity—Docetaxel—head and neck cancer	0.000257	0.0021	CcSEcCtD
Diclofenac—Gastrointestinal haemorrhage—Docetaxel—head and neck cancer	0.000257	0.0021	CcSEcCtD
Diclofenac—Agranulocytosis—Fluorouracil—head and neck cancer	0.000256	0.00209	CcSEcCtD
Diclofenac—CYP1A1—parotid gland—head and neck cancer	0.000255	0.00968	CbGeAlD
Diclofenac—Anorexia—Vinblastine—head and neck cancer	0.000254	0.00208	CcSEcCtD
Diclofenac—Migraine—Docetaxel—head and neck cancer	0.000253	0.00207	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Hydroxyurea—head and neck cancer	0.000252	0.00206	CcSEcCtD
Diclofenac—Discomfort—Hydroxyurea—head and neck cancer	0.000251	0.00205	CcSEcCtD
Diclofenac—SLCO1C1—lymph node—head and neck cancer	0.00025	0.0095	CbGeAlD
Diclofenac—Haemoglobin—Fluorouracil—head and neck cancer	0.000248	0.00202	CcSEcCtD
Diclofenac—Rhinitis—Fluorouracil—head and neck cancer	0.000247	0.00202	CcSEcCtD
Diclofenac—Haemorrhage—Fluorouracil—head and neck cancer	0.000246	0.00201	CcSEcCtD
Diclofenac—Hypoaesthesia—Fluorouracil—head and neck cancer	0.000245	0.002	CcSEcCtD
Diclofenac—Pharyngitis—Fluorouracil—head and neck cancer	0.000245	0.002	CcSEcCtD
Diclofenac—Oedema—Hydroxyurea—head and neck cancer	0.000243	0.00199	CcSEcCtD
Diclofenac—Infection—Hydroxyurea—head and neck cancer	0.000242	0.00197	CcSEcCtD
Diclofenac—Paraesthesia—Vinblastine—head and neck cancer	0.00024	0.00196	CcSEcCtD
Diclofenac—ABCC1—trachea—head and neck cancer	0.000239	0.0091	CbGeAlD
Diclofenac—Nervous system disorder—Hydroxyurea—head and neck cancer	0.000239	0.00195	CcSEcCtD
Diclofenac—Thrombocytopenia—Hydroxyurea—head and neck cancer	0.000238	0.00195	CcSEcCtD
Diclofenac—Skin disorder—Hydroxyurea—head and neck cancer	0.000236	0.00193	CcSEcCtD
Diclofenac—Dry skin—Docetaxel—head and neck cancer	0.000236	0.00192	CcSEcCtD
Diclofenac—Abdominal pain upper—Docetaxel—head and neck cancer	0.000235	0.00192	CcSEcCtD
Diclofenac—Anorexia—Hydroxyurea—head and neck cancer	0.000232	0.00189	CcSEcCtD
Diclofenac—Decreased appetite—Vinblastine—head and neck cancer	0.000232	0.00189	CcSEcCtD
Diclofenac—Aspartate aminotransferase increased—Docetaxel—head and neck cancer	0.000232	0.00189	CcSEcCtD
Diclofenac—Cramp muscle—Docetaxel—head and neck cancer	0.000232	0.00189	CcSEcCtD
Diclofenac—Toxic epidermal necrolysis—Docetaxel—head and neck cancer	0.000232	0.00189	CcSEcCtD
Diclofenac—Nasopharyngitis—Docetaxel—head and neck cancer	0.00023	0.00188	CcSEcCtD
Diclofenac—Pain—Vinblastine—head and neck cancer	0.000228	0.00186	CcSEcCtD
Diclofenac—Constipation—Vinblastine—head and neck cancer	0.000228	0.00186	CcSEcCtD
Diclofenac—Alanine aminotransferase increased—Docetaxel—head and neck cancer	0.000227	0.00185	CcSEcCtD
Diclofenac—ABCC4—thyroid gland—head and neck cancer	0.000222	0.00844	CbGeAlD
Diclofenac—Arrhythmia—Fluorouracil—head and neck cancer	0.00022	0.0018	CcSEcCtD
Diclofenac—Feeling abnormal—Vinblastine—head and neck cancer	0.00022	0.0018	CcSEcCtD
Diclofenac—Bronchospasm—Docetaxel—head and neck cancer	0.000219	0.00179	CcSEcCtD
Diclofenac—Gastrointestinal pain—Vinblastine—head and neck cancer	0.000218	0.00178	CcSEcCtD
Diclofenac—Alopecia—Fluorouracil—head and neck cancer	0.000218	0.00178	CcSEcCtD
Diclofenac—Dyspnoea—Hydroxyurea—head and neck cancer	0.000217	0.00177	CcSEcCtD
Diclofenac—Angina pectoris—Docetaxel—head and neck cancer	0.000217	0.00177	CcSEcCtD
Diclofenac—Somnolence—Hydroxyurea—head and neck cancer	0.000216	0.00177	CcSEcCtD
Diclofenac—Erythema—Fluorouracil—head and neck cancer	0.000215	0.00175	CcSEcCtD
Diclofenac—Dyspepsia—Hydroxyurea—head and neck cancer	0.000214	0.00175	CcSEcCtD
Diclofenac—CYP1A1—epithelium—head and neck cancer	0.000213	0.00809	CbGeAlD
Diclofenac—Decreased appetite—Hydroxyurea—head and neck cancer	0.000211	0.00173	CcSEcCtD
Diclofenac—Pancytopenia—Docetaxel—head and neck cancer	0.000211	0.00172	CcSEcCtD
Diclofenac—Abdominal pain—Vinblastine—head and neck cancer	0.000211	0.00172	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Hydroxyurea—head and neck cancer	0.00021	0.00172	CcSEcCtD
Diclofenac—Fatigue—Hydroxyurea—head and neck cancer	0.00021	0.00171	CcSEcCtD
Diclofenac—Pain—Hydroxyurea—head and neck cancer	0.000208	0.0017	CcSEcCtD
Diclofenac—Constipation—Hydroxyurea—head and neck cancer	0.000208	0.0017	CcSEcCtD
Diclofenac—Weight increased—Docetaxel—head and neck cancer	0.000202	0.00165	CcSEcCtD
Diclofenac—ALOX5—lymph node—head and neck cancer	0.000202	0.00769	CbGeAlD
Diclofenac—Vision blurred—Fluorouracil—head and neck cancer	0.000202	0.00165	CcSEcCtD
Diclofenac—Weight decreased—Docetaxel—head and neck cancer	0.000201	0.00164	CcSEcCtD
Diclofenac—Feeling abnormal—Hydroxyurea—head and neck cancer	0.0002	0.00164	CcSEcCtD
Diclofenac—Pneumonia—Docetaxel—head and neck cancer	0.000199	0.00163	CcSEcCtD
Diclofenac—Anaemia—Fluorouracil—head and neck cancer	0.000198	0.00162	CcSEcCtD
Diclofenac—Infestation—Docetaxel—head and neck cancer	0.000198	0.00162	CcSEcCtD
Diclofenac—Infestation NOS—Docetaxel—head and neck cancer	0.000198	0.00162	CcSEcCtD
Diclofenac—ABCC4—head—head and neck cancer	0.000197	0.00749	CbGeAlD
Diclofenac—PTGS1—connective tissue—head and neck cancer	0.000197	0.00749	CbGeAlD
Diclofenac—Hypersensitivity—Vinblastine—head and neck cancer	0.000197	0.0016	CcSEcCtD
Diclofenac—Stevens-Johnson syndrome—Docetaxel—head and neck cancer	0.000196	0.0016	CcSEcCtD
Diclofenac—SLC22A8—head—head and neck cancer	0.000195	0.00743	CbGeAlD
Diclofenac—Acute coronary syndrome—Docetaxel—head and neck cancer	0.000195	0.0016	CcSEcCtD
Diclofenac—Renal failure—Docetaxel—head and neck cancer	0.000195	0.00159	CcSEcCtD
Diclofenac—Neuropathy peripheral—Docetaxel—head and neck cancer	0.000194	0.00159	CcSEcCtD
Diclofenac—Myocardial infarction—Docetaxel—head and neck cancer	0.000194	0.00159	CcSEcCtD
Diclofenac—Jaundice—Docetaxel—head and neck cancer	0.000193	0.00158	CcSEcCtD
Diclofenac—Stomatitis—Docetaxel—head and neck cancer	0.000193	0.00158	CcSEcCtD
Diclofenac—Conjunctivitis—Docetaxel—head and neck cancer	0.000193	0.00157	CcSEcCtD
Diclofenac—Body temperature increased—Hydroxyurea—head and neck cancer	0.000192	0.00157	CcSEcCtD
Diclofenac—Leukopenia—Fluorouracil—head and neck cancer	0.000192	0.00157	CcSEcCtD
Diclofenac—Asthenia—Vinblastine—head and neck cancer	0.000191	0.00156	CcSEcCtD
Diclofenac—ABCC1—thyroid gland—head and neck cancer	0.000189	0.0072	CbGeAlD
Diclofenac—PTGS2—connective tissue—head and neck cancer	0.000188	0.00716	CbGeAlD
Diclofenac—CYP1A1—trachea—head and neck cancer	0.000188	0.00715	CbGeAlD
Diclofenac—Hepatobiliary disease—Docetaxel—head and neck cancer	0.000187	0.00153	CcSEcCtD
Diclofenac—Epistaxis—Docetaxel—head and neck cancer	0.000187	0.00153	CcSEcCtD
Diclofenac—PTGS1—epithelium—head and neck cancer	0.000187	0.00711	CbGeAlD
Diclofenac—Convulsion—Fluorouracil—head and neck cancer	0.000186	0.00152	CcSEcCtD
Diclofenac—Agranulocytosis—Docetaxel—head and neck cancer	0.000185	0.00151	CcSEcCtD
Diclofenac—Myalgia—Fluorouracil—head and neck cancer	0.000183	0.00149	CcSEcCtD
Diclofenac—Chest pain—Fluorouracil—head and neck cancer	0.000183	0.00149	CcSEcCtD
Diclofenac—Diarrhoea—Vinblastine—head and neck cancer	0.000183	0.00149	CcSEcCtD
Diclofenac—Discomfort—Fluorouracil—head and neck cancer	0.00018	0.00147	CcSEcCtD
Diclofenac—Hypersensitivity—Hydroxyurea—head and neck cancer	0.000179	0.00146	CcSEcCtD
Diclofenac—Haemoglobin—Docetaxel—head and neck cancer	0.000179	0.00146	CcSEcCtD
Diclofenac—PTGS2—epithelium—head and neck cancer	0.000179	0.00679	CbGeAlD
Diclofenac—Rhinitis—Docetaxel—head and neck cancer	0.000178	0.00146	CcSEcCtD
Diclofenac—Haemorrhage—Docetaxel—head and neck cancer	0.000178	0.00145	CcSEcCtD
Diclofenac—Hepatitis—Docetaxel—head and neck cancer	0.000178	0.00145	CcSEcCtD
Diclofenac—Hypoaesthesia—Docetaxel—head and neck cancer	0.000177	0.00145	CcSEcCtD
Diclofenac—Confusional state—Fluorouracil—head and neck cancer	0.000177	0.00144	CcSEcCtD
Diclofenac—Pharyngitis—Docetaxel—head and neck cancer	0.000177	0.00144	CcSEcCtD
Diclofenac—Dizziness—Vinblastine—head and neck cancer	0.000176	0.00144	CcSEcCtD
Diclofenac—Urinary tract disorder—Docetaxel—head and neck cancer	0.000176	0.00143	CcSEcCtD
Diclofenac—Oedema peripheral—Docetaxel—head and neck cancer	0.000175	0.00143	CcSEcCtD
Diclofenac—Anaphylactic shock—Fluorouracil—head and neck cancer	0.000175	0.00143	CcSEcCtD
Diclofenac—Oedema—Fluorouracil—head and neck cancer	0.000175	0.00143	CcSEcCtD
Diclofenac—Asthenia—Hydroxyurea—head and neck cancer	0.000175	0.00143	CcSEcCtD
Diclofenac—Urethral disorder—Docetaxel—head and neck cancer	0.000174	0.00142	CcSEcCtD
Diclofenac—Infection—Fluorouracil—head and neck cancer	0.000174	0.00142	CcSEcCtD
Diclofenac—Nervous system disorder—Fluorouracil—head and neck cancer	0.000172	0.0014	CcSEcCtD
Diclofenac—Thrombocytopenia—Fluorouracil—head and neck cancer	0.000171	0.0014	CcSEcCtD
Diclofenac—Visual impairment—Docetaxel—head and neck cancer	0.000171	0.0014	CcSEcCtD
Diclofenac—Tachycardia—Fluorouracil—head and neck cancer	0.000171	0.0014	CcSEcCtD
Diclofenac—Vomiting—Vinblastine—head and neck cancer	0.00017	0.00139	CcSEcCtD
Diclofenac—Erythema multiforme—Docetaxel—head and neck cancer	0.000168	0.00137	CcSEcCtD
Diclofenac—Headache—Vinblastine—head and neck cancer	0.000167	0.00136	CcSEcCtD
Diclofenac—Anorexia—Fluorouracil—head and neck cancer	0.000167	0.00136	CcSEcCtD
Diclofenac—Diarrhoea—Hydroxyurea—head and neck cancer	0.000166	0.00136	CcSEcCtD
Diclofenac—Eye disorder—Docetaxel—head and neck cancer	0.000166	0.00136	CcSEcCtD
Diclofenac—PTGS1—trachea—head and neck cancer	0.000165	0.00628	CbGeAlD
Diclofenac—Flushing—Docetaxel—head and neck cancer	0.000165	0.00135	CcSEcCtD
Diclofenac—Cardiac disorder—Docetaxel—head and neck cancer	0.000165	0.00135	CcSEcCtD
Diclofenac—Hypotension—Fluorouracil—head and neck cancer	0.000164	0.00134	CcSEcCtD
Diclofenac—Angiopathy—Docetaxel—head and neck cancer	0.000161	0.00132	CcSEcCtD
Diclofenac—Dizziness—Hydroxyurea—head and neck cancer	0.000161	0.00131	CcSEcCtD
Diclofenac—Immune system disorder—Docetaxel—head and neck cancer	0.000161	0.00131	CcSEcCtD
Diclofenac—Mediastinal disorder—Docetaxel—head and neck cancer	0.00016	0.00131	CcSEcCtD
Diclofenac—Chills—Docetaxel—head and neck cancer	0.00016	0.0013	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Fluorouracil—head and neck cancer	0.00016	0.0013	CcSEcCtD
Diclofenac—CYP2B6—lymphoid tissue—head and neck cancer	0.000159	0.00605	CbGeAlD
Diclofenac—Arrhythmia—Docetaxel—head and neck cancer	0.000159	0.0013	CcSEcCtD
Diclofenac—Nausea—Vinblastine—head and neck cancer	0.000158	0.00129	CcSEcCtD
Diclofenac—Insomnia—Fluorouracil—head and neck cancer	0.000158	0.00129	CcSEcCtD
Diclofenac—PTGS2—trachea—head and neck cancer	0.000158	0.00601	CbGeAlD
Diclofenac—Paraesthesia—Fluorouracil—head and neck cancer	0.000157	0.00128	CcSEcCtD
Diclofenac—Alopecia—Docetaxel—head and neck cancer	0.000157	0.00128	CcSEcCtD
Diclofenac—Dyspnoea—Fluorouracil—head and neck cancer	0.000156	0.00127	CcSEcCtD
Diclofenac—Mental disorder—Docetaxel—head and neck cancer	0.000156	0.00127	CcSEcCtD
Diclofenac—Somnolence—Fluorouracil—head and neck cancer	0.000156	0.00127	CcSEcCtD
Diclofenac—Malnutrition—Docetaxel—head and neck cancer	0.000155	0.00126	CcSEcCtD
Diclofenac—Erythema—Docetaxel—head and neck cancer	0.000155	0.00126	CcSEcCtD
Diclofenac—Vomiting—Hydroxyurea—head and neck cancer	0.000155	0.00126	CcSEcCtD
Diclofenac—Dyspepsia—Fluorouracil—head and neck cancer	0.000154	0.00126	CcSEcCtD
Diclofenac—Rash—Hydroxyurea—head and neck cancer	0.000153	0.00125	CcSEcCtD
Diclofenac—Dermatitis—Hydroxyurea—head and neck cancer	0.000153	0.00125	CcSEcCtD
Diclofenac—Headache—Hydroxyurea—head and neck cancer	0.000152	0.00124	CcSEcCtD
Diclofenac—Decreased appetite—Fluorouracil—head and neck cancer	0.000152	0.00124	CcSEcCtD
Diclofenac—Dysgeusia—Docetaxel—head and neck cancer	0.000152	0.00124	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Fluorouracil—head and neck cancer	0.000151	0.00123	CcSEcCtD
Diclofenac—CYP1A2—thyroid gland—head and neck cancer	0.000151	0.00574	CbGeAlD
Diclofenac—Back pain—Docetaxel—head and neck cancer	0.00015	0.00122	CcSEcCtD
Diclofenac—Pain—Fluorouracil—head and neck cancer	0.00015	0.00122	CcSEcCtD
Diclofenac—CYP2E1—lymphoid tissue—head and neck cancer	0.000149	0.00568	CbGeAlD
Diclofenac—Muscle spasms—Docetaxel—head and neck cancer	0.000149	0.00122	CcSEcCtD
Diclofenac—CYP1A1—thyroid gland—head and neck cancer	0.000149	0.00566	CbGeAlD
Diclofenac—Nausea—Hydroxyurea—head and neck cancer	0.000145	0.00118	CcSEcCtD
Diclofenac—Feeling abnormal—Fluorouracil—head and neck cancer	0.000144	0.00118	CcSEcCtD
Diclofenac—Anaemia—Docetaxel—head and neck cancer	0.000143	0.00117	CcSEcCtD
Diclofenac—ALB—lymph node—head and neck cancer	0.000142	0.00542	CbGeAlD
Diclofenac—Urticaria—Fluorouracil—head and neck cancer	0.000139	0.00114	CcSEcCtD
Diclofenac—Syncope—Docetaxel—head and neck cancer	0.000139	0.00113	CcSEcCtD
Diclofenac—Leukopenia—Docetaxel—head and neck cancer	0.000139	0.00113	CcSEcCtD
Diclofenac—Body temperature increased—Fluorouracil—head and neck cancer	0.000138	0.00113	CcSEcCtD
Diclofenac—ABCC4—lymph node—head and neck cancer	0.000138	0.00525	CbGeAlD
Diclofenac—PTGS2—lymphoid tissue—head and neck cancer	0.000138	0.00523	CbGeAlD
Diclofenac—Palpitations—Docetaxel—head and neck cancer	0.000137	0.00112	CcSEcCtD
Diclofenac—Loss of consciousness—Docetaxel—head and neck cancer	0.000136	0.00111	CcSEcCtD
Diclofenac—CYP2E1—thyroid gland—head and neck cancer	0.000136	0.00516	CbGeAlD
Diclofenac—Cough—Docetaxel—head and neck cancer	0.000135	0.0011	CcSEcCtD
Diclofenac—Convulsion—Docetaxel—head and neck cancer	0.000134	0.0011	CcSEcCtD
Diclofenac—Hypertension—Docetaxel—head and neck cancer	0.000134	0.00109	CcSEcCtD
Diclofenac—CYP1A1—head—head and neck cancer	0.000132	0.00502	CbGeAlD
Diclofenac—Arthralgia—Docetaxel—head and neck cancer	0.000132	0.00108	CcSEcCtD
Diclofenac—Chest pain—Docetaxel—head and neck cancer	0.000132	0.00108	CcSEcCtD
Diclofenac—Myalgia—Docetaxel—head and neck cancer	0.000132	0.00108	CcSEcCtD
Diclofenac—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—head and neck cancer	0.000131	0.00107	CcSEcCtD
Diclofenac—PTGS1—thyroid gland—head and neck cancer	0.000131	0.00497	CbGeAlD
Diclofenac—Hypersensitivity—Fluorouracil—head and neck cancer	0.000129	0.00105	CcSEcCtD
Diclofenac—Dry mouth—Docetaxel—head and neck cancer	0.000129	0.00105	CcSEcCtD
Diclofenac—CYP2B6—head—head and neck cancer	0.000128	0.00488	CbGeAlD
Diclofenac—Confusional state—Docetaxel—head and neck cancer	0.000127	0.00104	CcSEcCtD
Diclofenac—Anaphylactic shock—Docetaxel—head and neck cancer	0.000126	0.00103	CcSEcCtD
Diclofenac—Oedema—Docetaxel—head and neck cancer	0.000126	0.00103	CcSEcCtD
Diclofenac—Infection—Docetaxel—head and neck cancer	0.000126	0.00103	CcSEcCtD
Diclofenac—Shock—Docetaxel—head and neck cancer	0.000124	0.00102	CcSEcCtD
Diclofenac—Nervous system disorder—Docetaxel—head and neck cancer	0.000124	0.00101	CcSEcCtD
Diclofenac—Pruritus—Fluorouracil—head and neck cancer	0.000124	0.00101	CcSEcCtD
Diclofenac—Thrombocytopenia—Docetaxel—head and neck cancer	0.000124	0.00101	CcSEcCtD
Diclofenac—Tachycardia—Docetaxel—head and neck cancer	0.000123	0.00101	CcSEcCtD
Diclofenac—Skin disorder—Docetaxel—head and neck cancer	0.000123	0.001	CcSEcCtD
Diclofenac—Anorexia—Docetaxel—head and neck cancer	0.00012	0.000984	CcSEcCtD
Diclofenac—CYP2E1—head—head and neck cancer	0.00012	0.00458	CbGeAlD
Diclofenac—Diarrhoea—Fluorouracil—head and neck cancer	0.00012	0.000978	CcSEcCtD
Diclofenac—Hypotension—Docetaxel—head and neck cancer	0.000118	0.000964	CcSEcCtD
Diclofenac—ABCC1—lymph node—head and neck cancer	0.000118	0.00447	CbGeAlD
Diclofenac—PTGS1—head—head and neck cancer	0.000116	0.00441	CbGeAlD
Diclofenac—Dizziness—Fluorouracil—head and neck cancer	0.000116	0.000946	CcSEcCtD
Diclofenac—Musculoskeletal discomfort—Docetaxel—head and neck cancer	0.000115	0.00094	CcSEcCtD
Diclofenac—Insomnia—Docetaxel—head and neck cancer	0.000114	0.000933	CcSEcCtD
Diclofenac—Paraesthesia—Docetaxel—head and neck cancer	0.000113	0.000927	CcSEcCtD
Diclofenac—Dyspnoea—Docetaxel—head and neck cancer	0.000113	0.00092	CcSEcCtD
Diclofenac—Somnolence—Docetaxel—head and neck cancer	0.000112	0.000918	CcSEcCtD
Diclofenac—Vomiting—Fluorouracil—head and neck cancer	0.000111	0.000909	CcSEcCtD
Diclofenac—Dyspepsia—Docetaxel—head and neck cancer	0.000111	0.000908	CcSEcCtD
Diclofenac—PTGS2—head—head and neck cancer	0.000111	0.00422	CbGeAlD
Diclofenac—ABCB1—epithelium—head and neck cancer	0.00011	0.0042	CbGeAlD
Diclofenac—Rash—Fluorouracil—head and neck cancer	0.00011	0.000902	CcSEcCtD
Diclofenac—Dermatitis—Fluorouracil—head and neck cancer	0.00011	0.000901	CcSEcCtD
Diclofenac—Decreased appetite—Docetaxel—head and neck cancer	0.00011	0.000897	CcSEcCtD
Diclofenac—Headache—Fluorouracil—head and neck cancer	0.00011	0.000896	CcSEcCtD
Diclofenac—Gastrointestinal disorder—Docetaxel—head and neck cancer	0.000109	0.000891	CcSEcCtD
Diclofenac—Fatigue—Docetaxel—head and neck cancer	0.000109	0.00089	CcSEcCtD
Diclofenac—Constipation—Docetaxel—head and neck cancer	0.000108	0.000883	CcSEcCtD
Diclofenac—Pain—Docetaxel—head and neck cancer	0.000108	0.000883	CcSEcCtD
Diclofenac—Feeling abnormal—Docetaxel—head and neck cancer	0.000104	0.00085	CcSEcCtD
Diclofenac—Nausea—Fluorouracil—head and neck cancer	0.000104	0.000849	CcSEcCtD
Diclofenac—Gastrointestinal pain—Docetaxel—head and neck cancer	0.000103	0.000844	CcSEcCtD
Diclofenac—Abdominal pain—Docetaxel—head and neck cancer	9.99e-05	0.000816	CcSEcCtD
Diclofenac—Body temperature increased—Docetaxel—head and neck cancer	9.99e-05	0.000816	CcSEcCtD
Diclofenac—ABCB1—trachea—head and neck cancer	9.77e-05	0.00372	CbGeAlD
Diclofenac—Hypersensitivity—Docetaxel—head and neck cancer	9.31e-05	0.00076	CcSEcCtD
Diclofenac—CYP1A1—lymph node—head and neck cancer	9.24e-05	0.00352	CbGeAlD
Diclofenac—Asthenia—Docetaxel—head and neck cancer	9.07e-05	0.00074	CcSEcCtD
Diclofenac—Pruritus—Docetaxel—head and neck cancer	8.94e-05	0.00073	CcSEcCtD
Diclofenac—Diarrhoea—Docetaxel—head and neck cancer	8.65e-05	0.000706	CcSEcCtD
Diclofenac—ABCB1—lymphoid tissue—head and neck cancer	8.51e-05	0.00324	CbGeAlD
Diclofenac—Dizziness—Docetaxel—head and neck cancer	8.36e-05	0.000682	CcSEcCtD
Diclofenac—PTGS1—lymph node—head and neck cancer	8.12e-05	0.00309	CbGeAlD
Diclofenac—Vomiting—Docetaxel—head and neck cancer	8.04e-05	0.000656	CcSEcCtD
Diclofenac—Rash—Docetaxel—head and neck cancer	7.97e-05	0.000651	CcSEcCtD
Diclofenac—Dermatitis—Docetaxel—head and neck cancer	7.96e-05	0.00065	CcSEcCtD
Diclofenac—Headache—Docetaxel—head and neck cancer	7.92e-05	0.000647	CcSEcCtD
Diclofenac—PTGS2—lymph node—head and neck cancer	7.76e-05	0.00295	CbGeAlD
Diclofenac—ABCB1—thyroid gland—head and neck cancer	7.73e-05	0.00294	CbGeAlD
Diclofenac—Nausea—Docetaxel—head and neck cancer	7.51e-05	0.000613	CcSEcCtD
Diclofenac—ABCB1—head—head and neck cancer	6.85e-05	0.00261	CbGeAlD
Diclofenac—ABCB1—lymph node—head and neck cancer	4.8e-05	0.00183	CbGeAlD
Diclofenac—ALB—Platelet activation, signaling and aggregation—MAPK1—head and neck cancer	1.45e-05	0.000168	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.44e-05	0.000168	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—GSTM1—head and neck cancer	1.44e-05	0.000167	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—PIK3CA—head and neck cancer	1.43e-05	0.000166	CbGpPWpGaD
Diclofenac—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.42e-05	0.000165	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—head and neck cancer	1.42e-05	0.000165	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—head and neck cancer	1.42e-05	0.000165	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—TYMS—head and neck cancer	1.41e-05	0.000163	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—YAP1—head and neck cancer	1.4e-05	0.000162	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—GSTM1—head and neck cancer	1.39e-05	0.000162	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—IL2—head and neck cancer	1.39e-05	0.000161	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—GPX1—head and neck cancer	1.38e-05	0.00016	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—TP53—head and neck cancer	1.38e-05	0.00016	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—NAT2—head and neck cancer	1.37e-05	0.000159	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—PIK3CA—head and neck cancer	1.37e-05	0.000159	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—CYP1A1—head and neck cancer	1.37e-05	0.000159	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—CCND1—head and neck cancer	1.35e-05	0.000157	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—NOTCH1—head and neck cancer	1.35e-05	0.000157	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—DPYD—head and neck cancer	1.35e-05	0.000157	CbGpPWpGaD
Diclofenac—ALB—Metabolism—DPYD—head and neck cancer	1.34e-05	0.000156	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—NAT2—head and neck cancer	1.34e-05	0.000156	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—PTEN—head and neck cancer	1.33e-05	0.000155	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—GPX1—head and neck cancer	1.33e-05	0.000155	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.33e-05	0.000154	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—TP53—head and neck cancer	1.33e-05	0.000154	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—HRAS—head and neck cancer	1.32e-05	0.000153	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—CYP1A1—head and neck cancer	1.32e-05	0.000153	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.32e-05	0.000153	CbGpPWpGaD
Diclofenac—TTR—Disease—PIK3CA—head and neck cancer	1.32e-05	0.000153	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PTEN—head and neck cancer	1.31e-05	0.000152	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.3e-05	0.000151	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—PIK3CA—head and neck cancer	1.28e-05	0.000149	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—YAP1—head and neck cancer	1.28e-05	0.000149	CbGpPWpGaD
Diclofenac—ALB—Metabolism—YAP1—head and neck cancer	1.27e-05	0.000148	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—MAPK3—head and neck cancer	1.27e-05	0.000147	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—HRAS—head and neck cancer	1.27e-05	0.000147	CbGpPWpGaD
Diclofenac—ABCC1—Disease—NOTCH1—head and neck cancer	1.26e-05	0.000146	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—PIK3CA—head and neck cancer	1.25e-05	0.000146	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—NAT2—head and neck cancer	1.25e-05	0.000145	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—head and neck cancer	1.23e-05	0.000143	CbGpPWpGaD
Diclofenac—TTR—Disease—HRAS—head and neck cancer	1.22e-05	0.000141	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—MAPK1—head and neck cancer	1.21e-05	0.00014	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—EGFR—head and neck cancer	1.21e-05	0.00014	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—DPYD—head and neck cancer	1.2e-05	0.00014	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—head and neck cancer	1.19e-05	0.000139	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—TYMS—head and neck cancer	1.19e-05	0.000138	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—VEGFA—head and neck cancer	1.18e-05	0.000137	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GSTM1—head and neck cancer	1.18e-05	0.000137	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—DPYD—head and neck cancer	1.18e-05	0.000136	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—STAT3—head and neck cancer	1.17e-05	0.000136	CbGpPWpGaD
Diclofenac—ABCC4—Hemostasis—AKT1—head and neck cancer	1.17e-05	0.000135	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—PIK3CA—head and neck cancer	1.15e-05	0.000134	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—YAP1—head and neck cancer	1.14e-05	0.000133	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—head and neck cancer	1.14e-05	0.000132	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—GPX1—head and neck cancer	1.13e-05	0.000131	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—head and neck cancer	1.12e-05	0.000131	CbGpPWpGaD
Diclofenac—CXCR1—Signaling Pathways—AKT1—head and neck cancer	1.12e-05	0.00013	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MAPK3—head and neck cancer	1.12e-05	0.00013	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—YAP1—head and neck cancer	1.12e-05	0.000129	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—CYP1A1—head and neck cancer	1.12e-05	0.000129	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—DPYD—head and neck cancer	1.1e-05	0.000127	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	1.08e-05	0.000126	CbGpPWpGaD
Diclofenac—TTR—Disease—AKT1—head and neck cancer	1.08e-05	0.000125	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—NAT2—head and neck cancer	1.07e-05	0.000124	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—MAPK1—head and neck cancer	1.06e-05	0.000123	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—EGFR—head and neck cancer	1.06e-05	0.000123	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	1.05e-05	0.000122	CbGpPWpGaD
Diclofenac—PLA2G2A—Metabolism—AKT1—head and neck cancer	1.05e-05	0.000122	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—PIK3CA—head and neck cancer	1.05e-05	0.000121	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—YAP1—head and neck cancer	1.04e-05	0.000121	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	1.03e-05	0.00012	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PTGS2—head and neck cancer	1.03e-05	0.000119	CbGpPWpGaD
Diclofenac—ALB—Platelet activation, signaling and aggregation—AKT1—head and neck cancer	1.02e-05	0.000119	CbGpPWpGaD
Diclofenac—ABCB1—Integrated Pancreatic Cancer Pathway—AKT1—head and neck cancer	1.01e-05	0.000117	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PTGS2—head and neck cancer	1e-05	0.000116	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—IL2—head and neck cancer	9.74e-06	0.000113	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—HRAS—head and neck cancer	9.68e-06	0.000112	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.62e-06	0.000112	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	9.56e-06	0.000111	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—TYMS—head and neck cancer	9.45e-06	0.00011	CbGpPWpGaD
Diclofenac—CXCL8—GPCR downstream signaling—AKT1—head and neck cancer	9.42e-06	0.000109	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—PIK3CA—head and neck cancer	9.41e-06	0.000109	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—DPYD—head and neck cancer	9.38e-06	0.000109	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTGS2—head and neck cancer	9.37e-06	0.000109	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GSTM1—head and neck cancer	9.34e-06	0.000108	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—IL2—head and neck cancer	9.32e-06	0.000108	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—PIK3CA—head and neck cancer	9.22e-06	0.000107	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	9.16e-06	0.000106	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	9.15e-06	0.000106	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—CCND1—head and neck cancer	9.08e-06	0.000105	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—TYMS—head and neck cancer	9.08e-06	0.000105	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GSTM1—head and neck cancer	8.98e-06	0.000104	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PTEN—head and neck cancer	8.98e-06	0.000104	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—GPX1—head and neck cancer	8.94e-06	0.000104	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—TP53—head and neck cancer	8.92e-06	0.000104	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—YAP1—head and neck cancer	8.9e-06	0.000103	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—TYMS—head and neck cancer	8.89e-06	0.000103	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—CYP1A1—head and neck cancer	8.85e-06	0.000103	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GSTM1—head and neck cancer	8.79e-06	0.000102	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PTEN—head and neck cancer	8.76e-06	0.000102	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PTEN—head and neck cancer	8.73e-06	0.000101	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—GPX1—head and neck cancer	8.6e-06	9.98e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	8.59e-06	9.97e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling by GPCR—AKT1—head and neck cancer	8.55e-06	9.92e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—HRAS—head and neck cancer	8.53e-06	9.9e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—CYP1A1—head and neck cancer	8.51e-06	9.88e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—NOTCH1—head and neck cancer	8.47e-06	9.83e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—GPX1—head and neck cancer	8.42e-06	9.77e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.39e-06	9.74e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—TYMS—head and neck cancer	8.39e-06	9.73e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	8.34e-06	9.68e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—CYP1A1—head and neck cancer	8.33e-06	9.67e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GSTM1—head and neck cancer	8.29e-06	9.62e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—VEGFA—head and neck cancer	8.28e-06	9.6e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—NAT2—head and neck cancer	8.26e-06	9.58e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PTEN—head and neck cancer	8.17e-06	9.48e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTGS2—head and neck cancer	8.14e-06	9.44e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—GPX1—head and neck cancer	7.94e-06	9.21e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—VEGFA—head and neck cancer	7.92e-06	9.19e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTGS2—head and neck cancer	7.85e-06	9.11e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—STAT3—head and neck cancer	7.84e-06	9.1e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	7.83e-06	9.09e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—MAPK3—head and neck cancer	7.83e-06	9.09e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—TYMS—head and neck cancer	7.69e-06	8.92e-05	CbGpPWpGaD
Diclofenac—ALOX5—Metabolism—AKT1—head and neck cancer	7.69e-06	8.92e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—TYMS—head and neck cancer	7.64e-06	8.87e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GSTM1—head and neck cancer	7.6e-06	8.82e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GSTM1—head and neck cancer	7.56e-06	8.77e-05	CbGpPWpGaD
Diclofenac—TTR—Signaling Pathways—AKT1—head and neck cancer	7.53e-06	8.74e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MAPK3—head and neck cancer	7.49e-06	8.69e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	7.49e-06	8.69e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—MAPK1—head and neck cancer	7.45e-06	8.65e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—STAT3—head and neck cancer	7.31e-06	8.48e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—GPX1—head and neck cancer	7.28e-06	8.45e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	7.27e-06	8.44e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—DPYD—head and neck cancer	7.24e-06	8.4e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—GPX1—head and neck cancer	7.24e-06	8.4e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—CYP1A1—head and neck cancer	7.2e-06	8.36e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—CYP1A1—head and neck cancer	7.16e-06	8.31e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—MAPK1—head and neck cancer	7.13e-06	8.27e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—EGFR—head and neck cancer	7.12e-06	8.27e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PTEN—head and neck cancer	7.1e-06	8.23e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MAPK3—head and neck cancer	6.98e-06	8.1e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—YAP1—head and neck cancer	6.87e-06	7.98e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—TYMS—head and neck cancer	6.86e-06	7.96e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PTEN—head and neck cancer	6.84e-06	7.94e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	6.83e-06	7.92e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GSTM1—head and neck cancer	6.78e-06	7.87e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—TYMS—head and neck cancer	6.7e-06	7.77e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—head and neck cancer	6.69e-06	7.76e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—MAPK1—head and neck cancer	6.64e-06	7.71e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—EGFR—head and neck cancer	6.64e-06	7.71e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTGS2—head and neck cancer	6.63e-06	7.7e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GSTM1—head and neck cancer	6.62e-06	7.68e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—GPX1—head and neck cancer	6.5e-06	7.54e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—PIK3CA—head and neck cancer	6.46e-06	7.5e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	6.46e-06	7.49e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—CYP1A1—head and neck cancer	6.43e-06	7.46e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—GPX1—head and neck cancer	6.34e-06	7.36e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—PIK3CA—head and neck cancer	6.33e-06	7.35e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—CYP1A1—head and neck cancer	6.28e-06	7.28e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—TYMS—head and neck cancer	6.26e-06	7.26e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—TP53—head and neck cancer	6.25e-06	7.26e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GSTM1—head and neck cancer	6.18e-06	7.18e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—PIK3CA—head and neck cancer	6.18e-06	7.18e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—PIK3CA—head and neck cancer	6.16e-06	7.15e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—TP53—head and neck cancer	5.98e-06	6.94e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—HRAS—head and neck cancer	5.98e-06	6.94e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—GPX1—head and neck cancer	5.92e-06	6.87e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.92e-06	6.87e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.88e-06	6.83e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—CYP1A1—head and neck cancer	5.86e-06	6.8e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—head and neck cancer	5.83e-06	6.77e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PTEN—head and neck cancer	5.78e-06	6.71e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—PIK3CA—head and neck cancer	5.76e-06	6.69e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—HRAS—head and neck cancer	5.72e-06	6.64e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PTEN—head and neck cancer	5.48e-06	6.36e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—TYMS—head and neck cancer	5.35e-06	6.21e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—HRAS—head and neck cancer	5.33e-06	6.19e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GSTM1—head and neck cancer	5.29e-06	6.13e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	5.28e-06	6.13e-05	CbGpPWpGaD
Diclofenac—ALB—Hemostasis—AKT1—head and neck cancer	5.28e-06	6.13e-05	CbGpPWpGaD
Diclofenac—CYP2C18—Metabolism—AKT1—head and neck cancer	5.17e-06	6e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—GPX1—head and neck cancer	5.06e-06	5.87e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTGS2—head and neck cancer	5.06e-06	5.87e-05	CbGpPWpGaD
Diclofenac—CXCL8—Signaling Pathways—AKT1—head and neck cancer	5.05e-06	5.86e-05	CbGpPWpGaD
Diclofenac—UGT2B7—Metabolism—AKT1—head and neck cancer	5.03e-06	5.84e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—CYP1A1—head and neck cancer	5.01e-06	5.81e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—PIK3CA—head and neck cancer	5.01e-06	5.81e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTGS2—head and neck cancer	4.96e-06	5.75e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—STAT3—head and neck cancer	4.9e-06	5.69e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—PIK3CA—head and neck cancer	4.83e-06	5.6e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.82e-06	5.59e-05	CbGpPWpGaD
Diclofenac—ABCC1—Disease—AKT1—head and neck cancer	4.71e-06	5.46e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAPK3—head and neck cancer	4.68e-06	5.44e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTGS2—head and neck cancer	4.67e-06	5.42e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PTEN—head and neck cancer	4.59e-06	5.33e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—MAPK1—head and neck cancer	4.46e-06	5.17e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—EGFR—head and neck cancer	4.46e-06	5.17e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PTEN—head and neck cancer	4.41e-06	5.12e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PTEN—head and neck cancer	4.32e-06	5.02e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTGS2—head and neck cancer	4.28e-06	4.97e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTGS2—head and neck cancer	4.26e-06	4.94e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—TYMS—head and neck cancer	4.13e-06	4.79e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—head and neck cancer	4.12e-06	4.78e-05	CbGpPWpGaD
Diclofenac—UGT1A1—Metabolism—AKT1—head and neck cancer	4.09e-06	4.75e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—PIK3CA—head and neck cancer	4.08e-06	4.74e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GSTM1—head and neck cancer	4.08e-06	4.73e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PTEN—head and neck cancer	4.08e-06	4.73e-05	CbGpPWpGaD
Diclofenac—ABCC1—Metabolism—AKT1—head and neck cancer	3.94e-06	4.58e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—GPX1—head and neck cancer	3.91e-06	4.53e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—PIK3CA—head and neck cancer	3.87e-06	4.49e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—CYP1A1—head and neck cancer	3.87e-06	4.49e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTGS2—head and neck cancer	3.82e-06	4.44e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PTEN—head and neck cancer	3.74e-06	4.34e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTGS2—head and neck cancer	3.73e-06	4.33e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PTEN—head and neck cancer	3.71e-06	4.31e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—HRAS—head and neck cancer	3.58e-06	4.15e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTGS2—head and neck cancer	3.49e-06	4.05e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PTEN—head and neck cancer	3.33e-06	3.87e-05	CbGpPWpGaD
Diclofenac—PTGS1—Metabolism—AKT1—head and neck cancer	3.33e-06	3.87e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PTEN—head and neck cancer	3.25e-06	3.78e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—PIK3CA—head and neck cancer	3.24e-06	3.76e-05	CbGpPWpGaD
Diclofenac—PTGS2—Disease—AKT1—head and neck cancer	3.16e-06	3.67e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—PIK3CA—head and neck cancer	3.11e-06	3.61e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—PIK3CA—head and neck cancer	3.05e-06	3.54e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PTEN—head and neck cancer	3.04e-06	3.53e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTGS2—head and neck cancer	2.98e-06	3.46e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—PIK3CA—head and neck cancer	2.87e-06	3.34e-05	CbGpPWpGaD
Diclofenac—PTGS2—Metabolism—AKT1—head and neck cancer	2.65e-06	3.07e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—PIK3CA—head and neck cancer	2.64e-06	3.06e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—PIK3CA—head and neck cancer	2.62e-06	3.04e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PTEN—head and neck cancer	2.6e-06	3.02e-05	CbGpPWpGaD
Diclofenac—CYP2B6—Metabolism—AKT1—head and neck cancer	2.54e-06	2.95e-05	CbGpPWpGaD
Diclofenac—CYP2E1—Metabolism—AKT1—head and neck cancer	2.49e-06	2.89e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—PIK3CA—head and neck cancer	2.35e-06	2.73e-05	CbGpPWpGaD
Diclofenac—CYP1A1—Metabolism—AKT1—head and neck cancer	2.35e-06	2.73e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTGS2—head and neck cancer	2.3e-06	2.67e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—PIK3CA—head and neck cancer	2.3e-06	2.67e-05	CbGpPWpGaD
Diclofenac—CYP2C8—Metabolism—AKT1—head and neck cancer	2.15e-06	2.5e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—PIK3CA—head and neck cancer	2.15e-06	2.49e-05	CbGpPWpGaD
Diclofenac—ALB—Metabolism—AKT1—head and neck cancer	2.14e-06	2.48e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PTEN—head and neck cancer	2.01e-06	2.33e-05	CbGpPWpGaD
Diclofenac—CYP2C19—Metabolism—AKT1—head and neck cancer	1.92e-06	2.23e-05	CbGpPWpGaD
Diclofenac—ABCB1—Metabolism—AKT1—head and neck cancer	1.88e-06	2.18e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—PIK3CA—head and neck cancer	1.83e-06	2.13e-05	CbGpPWpGaD
Diclofenac—CYP2C9—Metabolism—AKT1—head and neck cancer	1.75e-06	2.03e-05	CbGpPWpGaD
Diclofenac—CYP1A2—Metabolism—AKT1—head and neck cancer	1.5e-06	1.74e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—PIK3CA—head and neck cancer	1.41e-06	1.64e-05	CbGpPWpGaD
Diclofenac—CYP3A4—Metabolism—AKT1—head and neck cancer	1.16e-06	1.34e-05	CbGpPWpGaD
